Pharmacology, Toxicology and Pharmaceutical Science
Plasminogen Activator
100%
Nanoparticle
97%
Urokinase
73%
Receptor
68%
Nanocapsule
61%
Superoxide Dismutase
55%
Endothelial Dysfunction
55%
Low Density Lipoprotein
42%
P-Glycoprotein
39%
Lung Cancer
38%
Plasminogen Activator Inhibitor 1
38%
Tempol
36%
Antibody Conjugate
36%
Tacrolimus
36%
Streptozotocin
36%
Diabetes Mellitus
36%
Thrombocyte Factor 4
36%
Docetaxel
36%
Acetylcholine
34%
Drug Delivery System
32%
Tissue Plasminogen Activator
31%
Fibrinolytic Agent
30%
Bioavailability
29%
Paclitaxel
27%
Palmitic Acid
27%
Lipoprotein
22%
Cancer Model
22%
Phenylephrine
22%
N Methyl Dextro Aspartic Acid Receptor
22%
Nitroxide
22%
Nanocarrier
21%
Epitope
21%
Polyethylene Glycol
21%
Nanoemulsion
21%
Glyceryl Trinitrate
21%
Tolerability
20%
N Methyl Dextro Aspartic Acid
19%
Superoxide
18%
Oxidizing Agent
18%
Oxybutynin
18%
Drug Transport
18%
Exendin 4
18%
Immunoglobulin F(ab) Fragment
18%
Oxidized Low Density Lipoprotein
18%
Lidocaine
18%
Overactive Bladder
18%
Antitumor Activity
18%
Pulmonary Drug Delivery
18%
Aspartic Acid
18%
Interstitial Cystitis
18%
Keyphrases
Endothelial Dysfunction
55%
Diabetic Rats
50%
Superoxide Dismutase Mimic
45%
Low-density Lipoprotein
40%
Low-density Lipoprotein Receptor
38%
Glucagon
36%
Substrate Drugs
36%
P-glycoprotein Substrate
36%
Tempol
36%
Vascular Cells
36%
Platelet Factor 4
36%
Streptozotocin-induced Diabetic Rats
36%
Tacrolimus
36%
Plasminogen Activator
36%
Nanocapsules
36%
Diabetes
32%
Glutamate
31%
Hyperglycemia
25%
Acetylcholine
23%
Vascular Function
22%
Nitroxide
22%
Oxidative Stress Markers
22%
Insulin
22%
Cell Surface
21%
Nanoparticles
20%
Polycarbophil
20%
Vascular Permeability
20%
Proteoglycan
20%
Lipoproteins
20%
Superoxide Dismutase Mimetic
20%
Catabolism
19%
Superoxide
19%
Atherogenesis
18%
Oxybutynin
18%
Human Plasma
18%
Immuno-nanoparticles
18%
Gluconeogenesis
18%
Neurotoxic Effects
18%
Oxidant Stress
18%
Laboratory Investigation
18%
Carbamoyl
18%
Drug Transport
18%
Dihydrolipoic Acid
18%
Intestinal Delivery
18%
Endogenous Types
18%
Sustained Drug Release
18%
High-performance Liquid Chromatography
18%
Biochemistry, Genetics and Molecular Biology
Urokinase
91%
Low-Density Lipoprotein
75%
Plasminogen Activator
64%
LDL Receptor
62%
Muscle Contraction
42%
Muscle Fiber Contraction
42%
Lipoprotein Receptor-Related Protein
41%
Blood Vessel Tone
38%
Glucagon
36%
Platelet Factor 4
36%
Phenylephrine
36%
Glutamic Acid
33%
Plasminogen Activator Inhibitor-1
32%
Lipoprotein
24%
Muscle Contractility
24%
Tissue Plasminogen Activator
24%
Amino Acid
23%
Macroglobulin
22%
Fibrinolysis
22%
Kringle Domain
22%
Proteoglycan
20%
Enzyme
19%
Nanoemulsion
18%
Oligonucleotide
18%
Nitric Oxide Synthase
18%
Microcirculation
18%
Blood Brain Barrier
18%
In Vitro Release
18%
Hexanoic Acid
18%
Retinoic Acid
18%
Antisense
18%
Gluconeogenesis
18%
Smooth Muscle Contraction
18%
Tretinoin
18%
Blood Vessel Permeability
18%
Cationic Lipid
18%
Apolipoprotein
18%
EC50
17%
Vasoconstriction
17%
Macrophage
13%
Internalization
13%
Vasodilatation
13%
Hyperglycemia
11%
calcium activated,phospholipid dependent protein kinase
9%
Enzymatic Activity
9%
Solution and Solubility
8%
C-Terminus
8%
Blood Pressure
8%
Blood Flow
6%